DEVELOPMENT OF AN EPIDEMIOLOGIC MODEL FOR TRACHOMA

沙眼流行病学模型的开发

基本信息

  • 批准号:
    2163673
  • 负责人:
  • 金额:
    $ 5.4万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-04-01 至 1996-03-31
  • 项目状态:
    已结题

项目摘要

Trachoma, caused by an ocular infection with C. trachomatis is the leading infectious cause of blindness worldwide. A number of epidemiologic studies of trachoma done by the investigators have elucidated the populations at risk for blinding sequelae of trachoma, and these studies suggest a number of potentially effective control strategies. This project would develop and test an epidemiologic model for trachoma which would consist of a transmission model for active disease, and a progression model for blinding sequela. We are proposing to model the non-homogeneous mixing of trachoma in a hyperendemic area by stratifying risk groups according to age, sex and household characteristics. The model will integrate current knowledge on chlamydial infection, transmission, disease, and blinding sequelae. Data for this model are available from the investigators unique, longitudinal series of data sets from trachoma hyperendemic areas of Tanzania and Oman. Development of such a model offers a powerful method for testing alternative control strategies in resource poor areas where time and cost constraints may limit field studies. Such strategies include programs to change hygiene behavior, mass antibiotic treatment, and surgical intervention for trichiasis/entropion. Data from this model will be critical for decision making on direction for trachoma control for the future.
沙眼是由眼部感染沙眼原体引起的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHEILA K WEST其他文献

SHEILA K WEST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHEILA K WEST', 18)}}的其他基金

Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control
监视
  • 批准号:
    8534135
  • 财政年份:
    2012
  • 资助金额:
    $ 5.4万
  • 项目类别:
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control
监视
  • 批准号:
    8536996
  • 财政年份:
    2012
  • 资助金额:
    $ 5.4万
  • 项目类别:
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control
监视
  • 批准号:
    8337987
  • 财政年份:
    2012
  • 资助金额:
    $ 5.4万
  • 项目类别:
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control
监视
  • 批准号:
    8723226
  • 财政年份:
    2012
  • 资助金额:
    $ 5.4万
  • 项目类别:
Surveillance & Treatment of Community Newcomers & Travelers for Trachoma Control
监视
  • 批准号:
    8917234
  • 财政年份:
    2012
  • 资助金额:
    $ 5.4万
  • 项目类别:
Yearly Mass Treatment C. Trachomatis: When Can We Stop?
每年的大规模治疗沙眼衣原体:我们什么时候可以停止?
  • 批准号:
    7390968
  • 财政年份:
    2006
  • 资助金额:
    $ 5.4万
  • 项目类别:
Yearly Mass Treatment C. Trachomatis: When Can We Stop?
每年的大规模治疗沙眼衣原体:我们什么时候可以停止?
  • 批准号:
    7483590
  • 财政年份:
    2006
  • 资助金额:
    $ 5.4万
  • 项目类别:
Yearly Mass Treatment C. Trachomatis: When Can We Stop?
每年的大规模治疗沙眼衣原体:我们什么时候可以停止?
  • 批准号:
    7289229
  • 财政年份:
    2006
  • 资助金额:
    $ 5.4万
  • 项目类别:
Yearly Mass Treatment C. Trachomatis: When Can We Stop?
每年的大规模治疗沙眼衣原体:我们什么时候可以停止?
  • 批准号:
    7034253
  • 财政年份:
    2006
  • 资助金额:
    $ 5.4万
  • 项目类别:
Cataract: Health Disparity for Older African-Americans
白内障:老年非洲裔美国人的健康差距
  • 批准号:
    6851421
  • 财政年份:
    2005
  • 资助金额:
    $ 5.4万
  • 项目类别:

相似海外基金

Investigating whether chlamydia trachomatis can increase the infectivity of HPV during genital tract infections
研究沙眼衣原体是否可以增加生殖道感染期间 HPV 的传染性
  • 批准号:
    10648156
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
Development of a multivalent rVSV vaccine against different Chlamydia trachomatis urogenital infections
针对不同沙眼衣原体泌尿生殖道感染的多价 rVSV 疫苗的开发
  • 批准号:
    488750
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
    Operating Grants
Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
鉴定介导 PD-L1 上调的沙眼衣原体因子
  • 批准号:
    10724569
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
The influence of rectal Chlamydia trachomatis infections on immunity and incident urogenital infections in women without an indication forrectal screening
直肠沙眼衣原体感染对无直肠筛查指征的女性免疫和泌尿生殖感染事件的影响
  • 批准号:
    10703789
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
The role of Chlamydia trachomatis specific HLA-E restricted CD8 T cell responses in clearance of infection
沙眼衣原体特异性 HLA-E 限制性 CD8 T 细胞反应在感染清除中的作用
  • 批准号:
    10646837
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
Understanding how motors drive the pathogenesis in host cells infected with Chlamydia trachomatis.
了解马达如何驱动感染沙眼衣原体的宿主细胞的发病机制。
  • 批准号:
    491115
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
    Fellowship Programs
CRISPR interference of essential stage-specific gene function in Chlamydia trachomatis
CRISPR 干扰沙眼衣原体必需阶段特异性基因功能
  • 批准号:
    10644789
  • 财政年份:
    2023
  • 资助金额:
    $ 5.4万
  • 项目类别:
Cervicovaginal microbiome, mucosal immunity, and pathogen factors that contribute to spontaneous clearance of Chlamydia trachomatis
宫颈阴道微生物群、粘膜免疫和有助于沙眼衣原体自发清除的病原体因素
  • 批准号:
    10463072
  • 财政年份:
    2022
  • 资助金额:
    $ 5.4万
  • 项目类别:
iSampleSmart!, an innovative, App-facilitated self-sampling screen and treat strategy for common bacterial STIs (Chlamydia trachomatis and Neisseria gonorrhoeae) for Canadian key populations
iSampleSmart!,一种创新的、应用程序辅助的自我采样筛查和治疗策略,适用于加拿大重点人群的常见细菌性传播感染(沙眼衣原体和淋病奈瑟菌)
  • 批准号:
    472740
  • 财政年份:
    2022
  • 资助金额:
    $ 5.4万
  • 项目类别:
    Operating Grants
Dissecting the role of the Inclusion membrane protein IncE, a master multi-tasking scaffolding protein, in the pathogenesis of Chlamydia trachomatis infections
剖析包涵膜蛋白 IncE(一种主要的多任务支架蛋白)在沙眼衣原体感染发病机制中的作用
  • 批准号:
    10453533
  • 财政年份:
    2022
  • 资助金额:
    $ 5.4万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了